Simon Peter Cooper - Aug 2, 2021 Form 3 Insider Report for Keros Therapeutics, Inc. (KROS)

Signature
/s/ Keith Regnante, Attorney-in-Fact
Stock symbol
KROS
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
3
Date filed
8/11/2021, 04:54 PM
Next filing
Aug 11, 2021

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney